CLINICAL_TRIALS
trial_result
· 2021-11-10
Clinical Trial Update: A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance [Phase 2]
Summary
A Phase 2 randomized study evaluated enzalutamide in men with localized prostate cancer undergoing active surveillance; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-11-10